MIRA INFORM REPORT

 

 

Report Date :

27.06.2012

 

IDENTIFICATION DETAILS

 

Name :

SAMRAT REMEDIES LIMITED

 

 

Registered Office :

1501, Phase III, GIDC,  Vapi – 396195, Gujarat

 

 

Country :

India

 

 

Financials (as on) :

31.03.2011

 

 

Date of Incorporation :

21.08.2003

 

 

Com. Reg. No.:

04-42774

 

 

Capital Investment / Paid-up Capital :

Rs.5.500 Millions

 

 

CIN No.:

[Company Identification No.]

U24231GJ2003PLC42774

 

 

IEC No.:

0305060724

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

SRTS06519C

 

 

PAN No.:

[Permanent Account No.]

AAJCS3844G

 

 

Legal Form :

A Closely Held Public Limited Liability Company

 

 

Line of Business :

Manufacturer and Trader of Chemicals, Drug Intermediates and Cattle Feeds.

 

 

No. of Employees :

43 [In Office : 8 and In Factory : 35] [Approximately]

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba (45)

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

 

 

 

 

Maximum Credit Limit :

USD 110000

 

 

Status :

Satisfactory

 

 

Payment Behaviour :

Usually Correct

 

 

Litigation :

Clear

 

 

Comments :

Subject is a well established company with satisfactory track. Directors are reported to be experienced and respectable businessmen. The financial position of the company has been improving. Trade relations are fair. Business is active. Payments are usually correct. Based on the valuation statement and networth the management appears to be having satisfactory means of their own. 

 

However, it would be advisable to take adequate securities while dealing with the subject.

 

 

NOTES:

 

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – September 30, 2011

 

Country Name

Previous Rating

(30.06.2011)

Current Rating

(30.09.2011)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

 

 

 

 

 

 

 

 

 

 

 

LOCATIONS

 

Registered Office/ Factory :

1501, Phase III, GIDC,  Vapi – 396195, Gujarat, India

Tel. No.:

91-260-3296545

Fax No.:

91-260-2427073

E-Mail :

samratplant@gmail.com

harshcorp@vsnl.net.in

harshcorp@mtnl.net.in

contact@samratremedies.com

Area :

19600 sq. ft.

Location :

Owned

 

 

Head Office :

303, 3rd Floor, Suyash, Hanuman Gali, Koldongri, Jagdish Nagar, Sahar Road, Andheri (E), Mumbai - 400069, Maharashtra, India

 

 

Branch Office :

Plot No. 1505, 3rd Phase, GIDC, Vapi – 396195, Gujarat, India

Area :

Owned

 

 

DIRECTORS

 

As on 30.09.2011

 

Name :

Mr. Champak Kantilal Parekh

Designation :

Director

Address :

3 Kamdhenu Nilayam, 5 Nanda Patkar Road, Vile Parle [East], Mumbai – 400057, Maharashtra, India

Date of Birth/Age :

31.10.1933

Qualification :

GDC and A

Date of Appointment :

25.08.2003

PAN No.:

00287189

 

 

Name :

Mr. Hitesh Champak Parekh

Designation :

Managing director

Address :

3 Kamdhenu Nilayam, 5 Nanda Patkar Road, Vile Parle [East], Mumbai – 400057, Maharashtra, India

Date of Birth/Age :

28.07.1965

Qualification :

B Pharma

Date of Appointment :

25.08.2003

DIN No.:

00287229

 

 

Name :

Mrs. Saroj Champak Parekh

Designation :

Director

Address :

3 Kamdhenu Nilayam, 5 Nanda Patkar Road, Vile Parle [East], Mumbai – 400057, Maharashtra, India

Date of Birth/Age :

10.10.1940

Qualification :

B. Com.  (Intermediate)

Date of Appointment :

16.09.2005

DIN No.:

00287298

 

 

Name :

Mrs. Sangeeta Hitesh Parekh

Designation :

Director

Address :

3 Kamdhenu Nilayam, 5 Nanda Patkar Road, Vile Parle [East], Mumbai – 400057, Maharashtra, India

Date of Birth/Age :

25.10.1966

Qualification :

B. Com.

Date of Appointment :

16.09.2005

DIN No.:

00287345

 

  

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

As on 30.09.2011

 

Names of Shareholders

 

No. of Shares

 

 

 

Hitesh C Parekh

 

462500

Hitesh C Parekh [HUF]

 

100000

Champak K Parekh

 

12500

Sangeeta H Parekh

 

462470

Saroj C Parekh

 

12500

Bindi V Mehta

 

10

Harish D Gandhi

 

10

Jayant L Shah

 

10

Total

 

1050000

 

As on 20.01.2012

 

Names of Allottes

 

No. of Shares Allotted

 

 

 

Central Chemical Inc.

 

81350

Total

 

81350

 

 

As on 30.09.2011

 

Equity Share Break up (Percentage of Total Equity)

 

 Category

 

Percentage

 

 

 

Directors or relatives of directors

 

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer and Trader of Chemicals, Drug Intermediates and Cattle Feeds.

 

 

Products :

Production Description

ITC Code No

 

Sodium Metaperiodate

28299000

Iodine

28012000

Potassium Iodide

28276010

 

  • Potassium Iodide
  • Potassium Iodate
  • Trimethyl Sulfoxonnium Iodide
  • Sodium Iodide
  • Sodium Metaperiodate
  • Potassium Metaperiodate
  • Copper Iodide
  • Methyl Iodide
  • Calcium Iodate
  • Methul 2- Iodobenzoate
  • Hydriodic Acid [56%]
  • 3,5-Diiodo Salicylic Acid

 

 

PRODUCTION STATUS

 

As on 31.03.2010

 

Particulars

Unit

Installed Capacity

Actual Production 

 

 

 

 

Organic and Inorganic Chemicals

MT

360.00

223.49

 

 

 

 

 

 

GENERAL INFORMATION

 

Suppliers :

·         Aarti Industries Limited

·         ACE Industries

·         Al-Can Exports Private Limited

·         Apsara Packagings

·         Bharat Acid and Chemical Company

·         CBC Company Limited

·         Central Chemicals Inc

·         Chaitanya Packaging

·         Chempharma

·         Deep Pharma-Chem Private Limited

·         Dhanuka Laboratories

·         Enopeck Security Seals (India)

·         GSPC Gas Company Limited

·         KDL Biotech Limited

 

 

Customers :

·         Aarti Industries Limited

·         Adani Pharmachem Private Limited

·         Apex Healthcare Limited

·         Artek Surfin Chemicals Limited

·         Artemis Biotech

·         Atul Limited

·         Auctus Pharma Limited

·         Bal Pharma Limited

·         Brundavan Lab Private Limited

·         Cadila Healthcare Limited

·         Century Enka Limited

·         Cipla Limited

·         Dhanuka Laboratories Limited

·         Evialis India Limited

·         Finar Chemicals Limited

 

 

No. of Employees :

43 [In Office : 8 and In Factory : 35] [Approximately]

 

 

Bankers :

§         Corporation Bank, SME- Marol Branch, Sarhar Bonanza Plaza, Marol, Andheri Kurla Road, Andheri East, Mumbai – 400059, Maharashtra, India

 

§         The Saraswat Co-operative Bank Limited,

Raja Shopping Center, New Nagardas Road, Andheri [East], Mumbai – 400069, Maharashtra, India  

 

§         ICICI Bank

§         ABN Amro Bank

§         HDFC Bank

§         Kotak Mahindra Bank

 

 

Facilities :

 

Secured Loan

31.03.2011

Rs. In Millions

31.03.2010

Rs. In Millions

 

 

 

Corporation Bank A/c 01080004

23.658

23.415

Corporation Bank Term Loan

16.008

21.458

Others

8.100

0.000

Total

47.766

44.873

 

 

Unsecured Loan

 

31.03.2011

Rs. In Millions

31.03.2010

Rs. In Millions

 

 

 

From Directors

26.849

23.949

From Others

4.249

13.729

Total

31.098

37.678

 

 

 

Banking Relations :

Satisfactory

 

 

Auditors :

 

Name :

Nalin S Parekh and Company

Chartered Accountants

Address :

302, Madhav Apartment, Jawahar Road, Ghatkopar [East], Mumbai – 400077, Maharashtra, India

Tel. No.:

91-22-25114552/ 25013488

E-Mail :

nalin@bom2.vsnl.net.in

PAN No.:

AABPP3409R

 

 

CAPITAL STRUCTURE

 

After 30.09.2011

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

1500000

Equity Shares

Rs.10/- each

Rs.15.000 Millions

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

1131350

Equity Shares

Rs.10/- each

Rs.11.314 Millions

 

 

 

 

 

As on 31.03.2011

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

600000

Equity Shares

Rs.10/- each

Rs.6.000 Millions

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

550000

Equity Shares

Rs.10/- each

Rs.5.500 Millions

 

 

 

 

 


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2011

31.03.2010

31.03.2009

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

5.500

5.500

5.500

2] Share Application Money

0.000

0.000

0.000

3] Reserves & Surplus

22.215

17.358

12.657

4] (Accumulated Losses)

0.000

0.000

0.000

NETWORTH

27.715

22.858

18.157

LOAN FUNDS

 

 

 

1] Secured Loans

47.766

44.873

33.141

2] Unsecured Loans

31.098

37.678

20.982

TOTAL BORROWING

78.864

82.551

54.123

DEFERRED TAX LIABILITIES

1.585

1.731

0.388

 

 

 

 

TOTAL

108.164

107.140

72.668

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

44.517

45.997

43.368

Capital work-in-progress

0.000

0.000

0.000

 

 

 

 

INVESTMENT

0.052

0.052

0.053

DEFERREX TAX ASSETS

0.000

0.000

0.000

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

45.390
19.172
7.015

 

Sundry Debtors

53.776
69.533
54.052

 

Cash & Bank Balances

11.193
14.645
8.365

 

Other Current Assets

0.000
0.000
0.000

 

Loans & Advances

10.445
8.860
7.576

Total Current Assets

120.804

112.210

77.008

Less : CURRENT LIABILITIES & PROVISIONS

 

 

 

 

Sundry Creditor

57.209
51.119
47.761

 

Other Current Liabilities

0.000
0.000
0.000

 

Provisions

0.000
0.000
0.000

Total Current Liabilities

57.209

51.119

47.761

Net Current Assets

63.595

61.091

29.247

 

 

 

 

MISCELLANEOUS EXPENSES

0.000

0.000

0.000

 

 

 

 

TOTAL

108.164

107.140

72.668

 


 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2011

31.03.2010

31.03.2009

 

SALES

 

 

 

 

 

Income

302.524

291.213

200.032

 

 

Other Income

2.121

1.301

1.280

 

 

TOTAL                                     (A)

304.645

292.514

201.312

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Cost of Sales

249.760

250.928

170.470

 

 

Administrative and Other Expenses

29.162

18.395

17.260

 

 

TOTAL                                     (B)

278.922

269.323

187.730

 

 

 

 

 

Less

PROFIT BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B)      (C)

25.723

23.191

13.582

 

 

 

 

 

Less

FINANCIAL EXPENSES                         (D)

12.559

10.513

5.975

 

 

 

 

 

 

PROFIT BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D)                                       (E)

13.164

12.678

7.607

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                     (F)

5.744

5.024

1.247

 

 

 

 

 

 

PROFIT BEFORE TAX (E-F)                               (G)

7.420

7.654

6.360

 

 

 

 

 

Less

TAX                                                                  (H)

2.563

2.531

2.049

 

 

 

 

 

 

PROFIT AFTER TAX (G-H)                                (I)

4.857

5.123

4.311

 

 

 

 

 

 

TOTAL IMPORTS

NA

157.405

102.511

 

 

 

 

 

 

Earnings Per Share (Rs.)

8.83

--

--

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2011

31.03.2010

31.03.2009

PAT / Total Income

(%)

1.59

1.75

2.14

 

 

 

 

 

Net Profit Margin

(PBT/Sales)

(%)

2.45

2.63

3.18

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

4.49

4.84

5.28

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.27

0.33

0.35

 

 

 

 

 

Debt Equity Ratio

(Total Liability/Networth)

 

4.91

5.85

5.61

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

2.11

2.20

1.61

 

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Check List by Info Agents

Available in Report (Yes / No)

1) Year of Establishment

Yes

2) Locality of the firm

Yes

3) Constitutions of the firm

Yes

4) Premises details

Yes

5) Type of Business

Yes

6) Line of Business•

Yes

7) Promoter’s background

Yes

8) No. of employees

Yes

9) Name of person contacted

No

10) Designation of contact person

No

11) Turnover of firm for last three years

Yes

12) Profitability for last three years

Yes

13) Reasons for variation <> 20%

--

14) Estimation for coming financial year

No

15) Capital in the business

Yes

16) Details of sister concerns

No

17) Major suppliers

Yes

18) Major customers

Yes

19) Payments terms

No

20) Export / Import details (if applicable)

No

21) Market information

--

22) Litigations that the firm / promoter

--

23) Banking Details

Yes

24) Banking facility details

Yes

25) Conduct of the banking account

--

26) Buyer visit details

--

27) Financials, if provided

Yes

28) Incorporation details, if applicable

Yes

29) Last accounts filed at ROC

Yes

30) Major Shareholders, if available

Yes

 

 

NOTE:

 

The registered office address of the company has shifted from “Plot No.1403, 3rd Phase, Near Gama Colony, GIDC, Vapi – 396195, Gujarat, India” to the present address w.e.f. 29.04.2010

 

 FIXED ASSETS

 

  • Building
  • Land
  • Office Equipments
  • Computer System
  • Plant and Machinery
  • Furniture and Fixture
  • Air Conditioners
  • Vehicles

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No records exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                              None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.57.07

UK Pound

1

Rs.88.96

Euro

1

Rs.71.40

 

INFORMATION DETAILS

 

Report Prepared by :

BSN

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

5

PAID-UP CAPITAL

1~10

5

OPERATING SCALE

1~10

5

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

5

--PROFITABILIRY

1~10

5

--LIQUIDITY

1~10

5

--LEVERAGE

1~10

5

--RESERVES

1~10

5

--CREDIT LINES

1~10

5

--MARGINS

-5~5

-

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

YES

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

TOTAL

 

45

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Unfavourable & favourable factors carry similar weight in credit consideration. Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

-

NB

                                       New Business

-

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.